Ji Yongling

Academic / Other · 3 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC Resectable Esophageal Cancer	Phase 2	2026-01-28
Not Yet Recruiting	Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-sma Carbon Ion Radiotheray	—	2025-06-16
Recruiting	Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC Non-Small Cell Lung Cancer	Phase 2	2024-05-01